
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES102
The HOPE study identified that ramipril compared with placebo reduced the risk of new
microalbuminuria and that both new microalbuminuria and progression of proteinuria was
higher for the diabetic group than the non-diabetic group.240

[@Unkown_date]

